viewOptiBiotix Health PLC

OptiBiotix Health signs a sweet deal with US manufacturer to produce a line of SweetBiotix

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara talks to Proactive London about their deal with an unnamed US company to manufacture and commercialise a line of its SweetBiotix.

The new partner has been granted an exclusive worldwide licence for the natural alternatives to sugar. In return, it will take on manufacturing and marketing costs of the roll-out and all future expenditure for a number of products.

The identity of the new partner is being kept confidential to protect its launch plans.

Quick facts: OptiBiotix Health PLC

Price: 50 GBX

Market: AIM
Market Cap: £43.97 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...



OptiBiotix Health expands key deals for its WellBiome and CholBiome

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive's Andrew Scott after announcing thy've amended its relationship with CTC Group, the company that is distributing and selling its CholBiomex3 product in the Philippines. The new agreement extends the product range from the...

on 17/7/20

2 min read